带状疱疹后遗神经痛物理治疗-2016英文文献

postherpeticneuralgiatreatment，physiotherapy2016.1.19，70Items:70Selectitem256002581.IntJDermatol.2015Apr;54(4):476-80.doi:10.1111/ijd.12385.Epub2015Jan20.Transcutaneouselectricalnervestimulationforchronicpost-herpeticneuralgia.IngMR1,HellreichPD,JohnsonDW,ChenJJ.Authorinformation1DepartmentofSurgery,UniversityofHawaiiSchoolofMedicine,Honolulu,HI,USA.AbstractPostherpeticneuralgiaremainsatherapeuticchallengefortheclinician.Manymodalitieshavebeenutilizedwithlimitedsuccess.Inthispilotrandomizedstudyofpatientswhowererefractorytopreviousmedicinaltreatment,thepatientsweretreatedwithtranscutaneousnervestimulationwithabiofeedbackcapability.Aftereverytwotreatmentswiththeshamandtruedevice,thepatientswererequiredtofilloutastandardneuropathicpainscalescore.Thepatientswereallowedtoselecttheotherdeviceafterthreeconsecutivetreatmentsiftheyfeltaninadequatedecreaseintheirpain.Thetruedevicewaschosenovertheshamdevicebyallpatients.Themajorityofthesepatientstreatedbythetruedevicereportedastatisticallysignificantdecreaseinpainscores(P0.001).FurtherinvestigationofthisFoodandDrugAdministration,class2accepted,electronicdeviceforreliefofpainiswarrantedforpatientswithahistoryofrecalcitrantpostherpeticneuralgia.©2015TheInternationalSocietyofDermatology.PMID:25600258[PubMed-indexedforMEDLINE]SimilararticlesPublicationTypes,MeSHTerms,GrantSupportPublicationTypesRandomizedControlledTrialResearchSupport,N.I.H.,ExtramuralResearchSupport,Non-U.S.Gov'tMeSHTermsSelectitem254592522.ClinNeurolNeurosurg.2014Dec;127:101-5.doi:10.1016/j.clineuro.2014.10.009.Epub2014Oct23.Peripheralfieldstimulationforthoracicpostherpeticneuropathicpain.ZiblyZ1,SharmaM1,ShawA1,DeogaonkarM2.Authorinformation1DepartmentofNeurosurgery,CenterofNeuromodulation,WexnerMedicalCenter,TheOhioStateUniversity,Columbus,USA.2DepartmentofNeurosurgery,CenterofNeuromodulation,WexnerMedicalCenter,TheOhioStateUniversity,Columbus,USA.Electronicaddress:[e-mail]:Postherpeticneuralgiaisachronic,debilitatingpainwithveryfewmanagementoptionsandisoftenrefractorytotreatment.Wepresentourexperiencewithaseriesof4patientswhounderwentsubcutaneousperipheralfieldstimulationfortreatmentofthoracicpostherpeticneuropathicpain.METHODS:Fourpatientswithintractablethoracicpostherpeticneuropathicpainwereoperatedaftermaximummedicaltreatmentandaneuropsychologicalevaluation.Multiplepercutaneouselectrodeswereplacedinthesubcutaneousplaneintheregionofpainfora7-daytrial.Followingasuccessfultrial(morethan50%reductionofpain),theelectrodesweretheninternalizedandattachedtoapulsegenerator.Visualanalogscores(VAS)werestudiedduringthepreoperative,immediatepostoperativeandlastfollow-upvisits.Long-termtreatmentresultsweredeterminedbyretrospectivereviewofmedicalrecords.Averagefollow-upperiodwas28.2months.RESULTS:All4patientsshowedpersistentimprovementintheirVASpainscoreswithanaverageimprovementofmorethan75%.Therewerenotreatmentfailuresandnocomplicationrequiringre-operationwasreported.CONCLUSION:Peripheralfieldstimulationforthetreatmentofpostherpeticneuropathicpainisasafeandeffectivemethodforpainreliefforanextremelycomplexproblemwithveryfewsolutions.Patientselectionandproperleadplacementismostimportantforthesuccessoftreatment.Copyright©2014ElsevierB.V.Allrightsreserved.KEYWORDS:Neuromodulation;Neuropathicpain;Peripheralfieldstimulation;Post-herpetic;ThoracicPMID:25459252[PubMed-indexedforMEDLINE]SimilararticlesMeSHTerms3.MinervaMed.2014Dec;105(6):515-27.[Topicalpharmacologicapproachwith5%lidocainemedicatedplasterinthetreatmentoflocalizedneuropathicpain].[ArticleinItalian]ProvincialiL1,LattanziS,ChiarloneR,FogliardiA,IntelligenteF,IraceC,LanzilottaM,PalombaR,StorelliE,ZampiM.Authorinformation1ClinicaNeurologica,DipartimentodiMedicinaSperimentaleeClinica,UniversitàPolitecnicadelleMarcheAncona,[e-mail]fferentclassesofdrugsisoftenunsatisfactoryandfrequentlyassociatedtoawiderangeofsideeffects.Internationalguidelinessuggestforthelocalizedneuropathicpainthetopicaltreatmentwith5%lidocainemedicatedplaster,aloneorassociatedtosystemicdrugs,asthefirstchoicesinceitsfavorableefficacyandtolerabilityprofile.Manyclinicalexperiencessupporttherationaleforusing5%lidocainemedicatedplasterindifferentkindsoflocalizedneuropathicpain,suchaspostherpeticandtrigeminalneuralgia,compressivesyndromes,painfuldiabeticpolyneuropathyandpainsecondarytotraumaorsurgicalinterventions.Thispaperreportsaseriesofclinicalcaseswhoseheterogeneitysuggeststhewideburdenofapplicabilityofthetopical5%lidocaine,eitheraloneandassociatedtosystemicdrugs.Allthedescribedconditionswerecharacterizedbyahighlyintensepain,notadequatelycontrolledbyactualmedications,whichimprovedaftertheuseoftopicallidocaine.Thegoodresponsetolidocaineallowedthereduction,ofeventhewithdrawal,ofconcurrentdrugsandimprovedthepatients'qualityoflife.PMID:25392960[PubMed-indexedforMEDLINE]SimilararticlesPublicationTypes,MeSHTerms,SubstancesPublicationTypesCaseReportsEnglishAbst